Impact of immunosuppressive regimen on ICU acquired pneumonia in critically ill COVID-19.

Minerva anestesiologica（2023）

引用 0|浏览0

暂无评分

摘要

In critically ill COVID-19, HDMB significantly increases the risk of IAP whereas DXM alone, nor in combination with tocilizumab, did not.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要